Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S Reading

Establishing Optimal Quantitative-Polymerase Chain Reaction Assays for Routine Diagnosis and Tracking of Minimal Residual Disease in JAK2-V617F-associated Myeloproliferative Neoplasms: A Joint European LeukemiaNet/MPN&MPNr-EuroNet (COST Action BM0902) Study

Leukemia

English

Related publications

Characterization of CD34+ Hematopoietic Progenitor Cells in JAK2 V617F and CALR -Mutated Myeloproliferative Neoplasms

English

Development and Validation of a Quantitative Polymerase Chain Reaction Assay to Evaluate Minimal Residual Disease for T-Cell Acute Lymphoblastic Leukemia and Follicular Lymphoma

American Journal of Pathology

Forensic Medicine

Pathology

1999

English

JAK2 V617F Hematopoietic Clones Are Present Several Years Prior to MPN Diagnosis and Follow Different Expansion Kinetics

Blood advances

Hematology

2017

English

JAK2 Exon 12 Mutated Polycythemia Vera: Mayo-Careggi MPN Alliance Study of 33 Consecutive Cases and Comparison With JAK2 V617F Mutated Disease

American Journal of Hematology

Hematology

2018

English

Serum Based Polymerase Chain Reaction and Enzyme Linked Immunosorbent Assays for Diagnosis of Bovine Brucellosis

Indian Journal of Animal Research

English

JAK2 and MPL Mutations in Myeloproliferative Neoplasms: Discovery and Science

English

Minimal Residual Disease by Flow Cytometry and Allelic-Specific Oligonucleotide Real-Time Quantitative Polymerase Chain Reaction in Patients With Myeloma Receiving Lenalidomide Maintenance: A Pooled Analysis

English

Progressive Diagnosis of Chronic Myeloproliferative Neoplasms: A Case Study

American Society for Clinical Laboratory Science

2019

English

Routine Blood Examinations Combined With Morphological Analysis for the Diagnosis of Myelodysplastic/Myeloproliferative Neoplasms

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S Reading

Establishing Optimal Quantitative-Polymerase Chain Reaction Assays for Routine Diagnosis and Tracking of Minimal Residual Disease in JAK2-V617F-associated Myeloproliferative Neoplasms: A Joint European LeukemiaNet/MPN&MPNr-EuroNet (COST Action BM0902) Study

Related publications

Characterization of CD34+ Hematopoietic Progenitor Cells in JAK2 V617F and CALR -Mutated Myeloproliferative Neoplasms

Development and Validation of a Quantitative Polymerase Chain Reaction Assay to Evaluate Minimal Residual Disease for T-Cell Acute Lymphoblastic Leukemia and Follicular Lymphoma

JAK2 V617F Hematopoietic Clones Are Present Several Years Prior to MPN Diagnosis and Follow Different Expansion Kinetics

JAK2 Exon 12 Mutated Polycythemia Vera: Mayo-Careggi MPN Alliance Study of 33 Consecutive Cases and Comparison With JAK2 V617F Mutated Disease

Serum Based Polymerase Chain Reaction and Enzyme Linked Immunosorbent Assays for Diagnosis of Bovine Brucellosis

JAK2 and MPL Mutations in Myeloproliferative Neoplasms: Discovery and Science

Minimal Residual Disease by Flow Cytometry and Allelic-Specific Oligonucleotide Real-Time Quantitative Polymerase Chain Reaction in Patients With Myeloma Receiving Lenalidomide Maintenance: A Pooled Analysis

Progressive Diagnosis of Chronic Myeloproliferative Neoplasms: A Case Study

Routine Blood Examinations Combined With Morphological Analysis for the Diagnosis of Myelodysplastic/Myeloproliferative Neoplasms